Metrics to compare | HINL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHINLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.8x | 16.0x | −0.4x | |
PEG Ratio | 0.71 | 0.21 | 0.00 | |
Price/Book | 3.6x | 2.7x | 2.6x | |
Price / LTM Sales | 1.9x | 2.1x | 3.0x | |
Upside (Analyst Target) | 6.8% | 20.7% | 49.7% | |
Fair Value Upside | Unlock | 25.3% | 7.3% | Unlock |
Highnoon Laboratories Limited, together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally. The company offers medicines in various drug forms and brands for allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynecology, pediatrics, respiratory, and urology therapeutic areas. It exports its products. The company was incorporated in 1984 and is based in Lahore, Pakistan.